- Home
- COGT vs CMP Comparison
COGT vs CMP Comparison
Compare COGT & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- CMP
- Stock Information
- Founded
- COGT 2014
- CMP 1993
- Country
- COGT United States
- CMP United States
- Employees
- COGT N/A
- CMP N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- CMP Other Metals and Minerals
- Sector
- COGT Health Care
- CMP Basic Materials
- Exchange
- COGT Nasdaq
- CMP Nasdaq
- Market Cap
- COGT 555.6M
- CMP 493.5M
- IPO Year
- COGT 2018
- CMP 2003
- Fundamental
- Price
- COGT $5.44
- CMP $19.20
- Analyst Decision
- COGT Buy
- CMP Buy
- Analyst Count
- COGT 6
- CMP 2
- Target Price
- COGT $15.20
- CMP $17.50
- AVG Volume (30 Days)
- COGT 1.2M
- CMP 959.6K
- Earning Date
- COGT 05-06-2025
- CMP 05-07-2025
- Dividend Yield
- COGT N/A
- CMP N/A
- EPS Growth
- COGT N/A
- CMP N/A
- EPS
- COGT N/A
- CMP N/A
- Revenue
- COGT N/A
- CMP $1,213,500,000.00
- Revenue This Year
- COGT N/A
- CMP $10.97
- Revenue Next Year
- COGT N/A
- CMP $1.69
- P/E Ratio
- COGT N/A
- CMP N/A
- Revenue Growth
- COGT N/A
- CMP 5.81
- 52 Week Low
- COGT $3.72
- CMP $7.51
- 52 Week High
- COGT $12.61
- CMP $20.75
- Technical
- Relative Strength Index (RSI)
- COGT 56.27
- CMP 68.56
- Support Level
- COGT $4.80
- CMP $18.69
- Resistance Level
- COGT $4.99
- CMP $20.75
- Average True Range (ATR)
- COGT 0.31
- CMP 0.86
- MACD
- COGT 0.07
- CMP -0.19
- Stochastic Oscillator
- COGT 88.56
- CMP 45.23
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.